Isracann Biosciences Inc.
IPOT.CN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.64M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.64 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.03 |
| Beta | 0.03 |
| Outstanding Shares | 158,455,213 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.47 |
|---|---|
| PEG | 1.45 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Isracann Biosciences Inc.
0CEO: Ajay Singh Kaila
Isracann Biosciences Inc., operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure. Additiona...